Hopp til innhold
NHI.no
Annonse

Psoriasis, symptomer: Quiz

Innhold i artikkelen

Har du fått med deg det viktigste i dette dokumentet? Da utfordrer vi deg til å ta vår quiz om psoriasis!

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Psoriasis . Referanselisten for dette dokumentet vises nedenfor

  1. Weigle N, McBane S. Psoriasis. Am Fam Physician 2013; 87: 626-33. PubMed
  2. Coates LC, Moverley AR, McParland L, et al. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. Lancet. 2015;386(10012):2489-98. PubMed
  3. Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013 Jun;168(6):1303-10. PMID: 23374051. PubMed
  4. Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet. 2021 Apr 3;397(10281):1301-1315. PMID: 33812489. PubMed
  5. Chen T-L, Lee L-L, Huang H-K, et al. Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease A Systematic Review and Meta-analysis. JAMA Dermatol 2021. pmid:34851364 PubMed
  6. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509. PubMed
  7. Roubille C, Richer V, Starnino T, et al. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J Rheumatol 2015; 42: 1767-80. pmid:26178281 PubMed
  8. Alinaghi F, Calov M, Kristensen LE, et al. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. PMID: 29928910. PubMed
  9. Jabbar-Lopez ZK, Wu KC, Reynolds NJ. Newer agents for psoriasis in adults. BMJ. 2014 Jul 9;349:g4026. doi: 10.1136/bmj.g4026. PMID: 25008099 PubMed
  10. Ryan C, Menter A. Psoriasis and cardiovascular disorders. G Ital Dermatol Venereol 2012; 147: 189-202. pmid:22481581 PubMed
  11. Burden-Teh E, Phillips RC, Thomas KS, et al . A systematic review of diagnostic criteria for psoriasis in adults and children: evidence from studies with a primary aim to develop or validate diagnostic criteria. Br J Dermatol 2018; 178: 1035-1043. PubMed
  12. Pogorelov D, Tschesche A, Balakirski G, Hofmann SC. Generalized Pustular Psoriasis of Pregnancy Successfully Treated With Certolizumab Pegol: A Case Report and Literature Review. Cureus. 2024 May 7;16(5):e59832. PMID: 38846233. PubMed
  13. Langenbruch A, Radtke MA, Krensel M, et al.. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. . Br J Dermatol. 2014; 171: 1123-1128. pmid:25040629 PubMed
  14. Mason AR, Mason J, Cork M, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2013. pmid:23543539. PubMed
  15. Schlager JG, Rosumeck S, Werner RN, et al. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev 2016. pmid:26915340. PubMed
  16. Samarasekera EJ, Sawyer L, Wonderling D, et al . Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. British Journal of Dermatology 2013; 168: 954-67. pmid:23413913. PubMed
  17. Wang C, Lin A. Efficacy of topical calcineurin inhibitors in psoriasis. J Cutan Med Surg. 2014;18(1):8-14. PubMed
  18. NFDV: Veiledende anbefalinger for systemisk behandling av psoriasis vulgaris, versjon 2, mars 2023, siden lest 23.03.24 www.legeforeningen.no
  19. Montaudié H, Sbidian E, Paul C, et al . Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol 2011; 2: 12-18. pmid:21388454. PubMed
  20. Maza A, Montaudie H, Sbidian E, et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Euro Acad Dermatol Venereol. 2011;25(suppl 2):19-27. PMID: 21388455. PubMed
  21. Dupire G, Droitcourt C, Hughes C, et al . Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2019. pmid:30835819. PubMed
  22. European Dermatology Forum. Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris. Last updated 07/2020. siden lest 08.04.2024 www.edf.one
  23. Leisner MZ, Riis JL, Schwartz BS et al. Psoriasis and Risk of Mental Disorders in Denmark. JAMA Dermatol 2019.0039 pmid:31066861 PubMed
  24. Balda A, Wani I, Roohi TF, et al. Psoriasis and skin cancer - Is there a link? Int Immunopharmacol. 2023 Aug;121:110464. PMID: 37390565. PubMed
  25. Li X, Andersen KM, Chang H-Y, et al. Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis. Ann Rheum Dis 2019. pmid:31672774 PubMed
  26. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009; 61: 1373-8. pmid:19790120 PubMed
  27. Zhao SS, Yiu ZZN, Barton A, Bowes J. Association of Lipid-Lowering Drugs With Risk of Psoriasis A Mendelian Randomization Study. JAMA Dermatol 2023. pmid:36696131 PubMed
  28. Philipp S, Wolk K, Kreutzer S, et al. The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder. Expert Opin Ther Targets 2006;10:817-831. PubMed
  29. Lapolla W, Yentzer BA, Bagel J, et al. A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol. 2011;64:936-949. PubMed
  30. Sbidian E, Chaimani A, Afach S, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No.: CD011535. The Cochrane Library
  31. Meng Y, Dongmei L, Yanbin P, et al. Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol 2014; 39: 696-707. pmid:25039593.
  32. Meng Y, Dongmei L, Yanbin P, et al . Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis. Clin Exp Dermatol 2014; 39: 696-707. pmid:25039593. PubMed
  33. Langley RG, Elewski BE, Lebwohl MN, et al. Secukinumab in plaque psoriasis--results of two phase 3 trials. N Engl J Med. 2014;371:326-338. PubMed
  34. Pouplard C, Brenaut E, Horreau C, et al. Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol. 2013;27(suppl 3):36-46. PMID: 23845151 PubMed
  35. Trafford AM, Parisi R, Kontopantelis E, et al. Association of Psoriasis With the Risk of Developing or Dying of Cancer A Systematic Review and Meta-analysis. JAMA Dermatol 2019. pmid:31617868 PubMed
  36. Ahlehoff O, Skov L, Gislason G, et al . Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 2013; 273: 197-204. pmid:22963528. PubMed
  37. Crowley JJ, Weinberg JM, Wu JJ et al. Treatment of Nail Psoriasis. JAMA Dermatol 2015; 151(1): 87-94. pmid:25471223 PubMed
  38. Horn EJ, Fox KM, Patel V, et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007;57(6):957-62. PubMed
  39. Smith CH, Jabbar-Lopez ZK, Yiu ZZ, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol. 2017;177(3):628-36. PubMed
  40. Giet G, Senterre Y, Lebas E, et al . Le phénomène de Köbner en dermatologie Köbner's phenomenon in dermatology.. Rev Med Liege 2021; 76: 651-656. pmid:34477334. PubMed
  41. Ko SH, Chi CC, Yeh ML, et al. Lifestyle changes for treating psoriasis. Cochrane Database Syst Rev. 2019 Jul 16;7(7):CD011972. PMID: 31309536. PubMed
Annonse
Annonse